Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
China
· Delayed Price · Currency is CNY 27.62
+0.01 (0.04%)
At close: Apr 14, 2025, 2:57 PM CST
SHA:688161 Revenue
In the year 2024, Shandong Weigao Orthopaedic Device had annual revenue of 1.45B CNY with 13.14% growth. Shandong Weigao Orthopaedic Device had revenue of 368.91M in the quarter ending December 31, 2024, with 83.52% growth.
Revenue
1.45B
Revenue Growth
+13.14%
P/S Ratio
7.12
Revenue / Employee
657.10K
Employees
2,210
Market Cap
10.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.45B | 168.64M | 13.14% |
| Dec 31, 2023 | 1.28B | -774.42M | -37.63% |
| Dec 31, 2022 | 2.06B | -95.57M | -4.44% |
| Dec 31, 2021 | 2.15B | 329.77M | 18.08% |
| Dec 31, 2020 | 1.82B | 249.77M | 15.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |